Clinical Trial Update: A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of Vipoglanstat in women with endometriosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Vipoglanstat

Snippet

Sponsor: Gesynta Pharma AB | Conditions: Endometriosis | Phase 2 | Status: RECRUITING